Brief: Vistin Pharma Q3 Revenue Down At Nok 108.4 Million
29/10/2026 06:47
BRIEF-Vistin Pharma Q3 Revenue Down At Nok 108.4 Million Oct 29 (Reuters) - Vistin Pharma ASA VISTN.OL:
Q3 REVENUE NOK 108.4 MILLION
Q3 NET INCOME NOK 11 MILLION
Q3 EBITDA NOK 19 MILLION
BOARD OF DIRECTORS HAS RESOLVED TO PAY AN ADDITIONAL CASH DIVIDEND OF NOK 0.50 PER SHARE IN NOVEMBER
Source text: ID:nGNE2z0Jz8
Further company coverage: VISTN.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))